E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125
Clinical trial NCT01133756 · TERMINATED
Trial details
- NCT number
- NCT01133756
- Sponsor
- Eisai Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2012-02-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.